02/19/2016 - 11:26am

Sleeping less than seven hours per day is associated with an increased risk of developing chronic conditions such as obesity, diabetes, high blood pressure, heart disease, stroke and frequent mental distress.

02/19/2016 - 10:24am
The demonstration projects that are the subject of the RFP are intended to contribute to the fulfillment of the objectives behind a grant from the Centers for Disease Control and Prevention. 
02/17/2016 - 12:02pm

Impax Laboratories has gained approval for its generic of the extended-release ADHD treatment. 

02/16/2016 - 1:23pm

The intravenous infusion drug is indicated to treat certain types of various cancers. 

02/12/2016 - 4:08pm

Generics manufacturerer Vensun Pharmaceuticals has added an industry veteran to head up its regulatory affairs and compliance operations. 

02/12/2016 - 1:18pm

According to a new survey, among patients with MDD who take their medication as directed 42% said they still experience symptoms at least once a week and 26% said they experience symptoms several times a week. 

02/12/2016 - 11:54am

The study isn't relevant to the 14-day recommended use of over-the-counter PPIs in treatment of frequent heartburn, however. 

02/11/2016 - 12:37pm

The Senate Judiciary Committee approved a piece of legislation aimed at curbing prescription drug abuse and ensuring legitimate patient access by encouraging collaboration between health and enforcement agencies. 

02/10/2016 - 5:45pm

Specialty pharmaceutical company Meda is being acquired by Mylan, expanding Mylan's reach into emerging markets, building on its recent specialty and branded generics acquisitions and creating an OTC division worth about $1 billion.